Skip to main content
. 2021 Jan 14;11:605939. doi: 10.3389/fendo.2020.605939

Table 2.

Cycle characteristics according to different protocols.

First GnRH-antagonist stimulation (325 cycles) Minimal ovarian stimulation P a P b
First (374 cycles) Multiple (733 cycles)
Duration of Gn stimulation (days) 9 (8, 10) 6 (4, 8) / <0.001 /
Total dose of Gn (IU) 2400 (1800, 2925) 900 (600.00, 1256.25) / <0.001 /
Peak E2 level at trigger day (pmol/L) 7585 (4213.5, 11666.0)
(N=320)
2707 (1630, 4815)
(N=365)
/ <0.001 /
P level at trigger day (nmol/L) 2.64 (1.623, 3.683)
(N=68)
1.36 (1.032, 3.105)
(N=96)
/ 0.005 /
LH level at trigger day (U/L) 3.14 (2.205, 5.210) (N=67) 7.96 (5.318, 13.858) (N=96) / <0.001 /
Endometrial thickness at trigger day (mm) 9 (8.5, 10.4) 6 (5.0, 8.2) / <0.001 /
ICSI/IVF 100/225 104/270 / 0.390 /
Number of oocytes retrieved 7 (4, 10) 2 (1, 4) 4 (2, 7) <0.001 <0.001
Number of MII oocytes 5 (3, 8.25) 2 (1, 3) 3 (1, 4) <0.001 <0.001
Number of fertilized oocytes 5 (3, 7) 2 (1, 3) 3 (1, 5) <0.001 <0.001
Number of viable embryos 2 (1, 4) 1 (0, 2) 2 (1,3) <0.001 <0.001
a

First GnRH-antagonist vs. first minimal ovarian stimulation.

b

bFirst GnRH-antagonist vs. multiple minimal ovarian stimulation.

Gn, gonatrodopin; IVF, in vitro fertilization; ICSI, intracytoplasmic sperm injection; MII, meiosis II.